Export this record

Export record to excel

File type to download

Beta version

Select record 1

ArticlesPeer ReviewedFull Text

Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study

Author / Creator:Schuster, Stephen J, MD ; Tam, Constantine S, MD ; Borchmann, Peter, MD ; Worel, Nina, MD ; McGuirk, Joseph P, DO ; Holte, Harald, MD ; Waller, Edmund K, MD ; Jaglowski, Samantha, MD ; Bishop, Michael R, MD ; Damon, Lloyd E, MD ; Foley, Stephen Ronan, MD ; Westin, Jason R, MD ; Fleury, Isabelle, MD ; Ho, P Joy, MBBS ; Mielke, Stephan, MD ; Teshima, Takanori, MD ; Janakiram, Murali, MD ; Hsu, Jing-Mei, MD ; Izutsu, Koji, MD ; Kersten, Marie José, MD ; Ghosh, Monalisa, MD ; Wagner-Johnston, Nina, MD ; Kato, Koji, MD ; Corradini, Paolo, MD ; Martinez-Prieto, Marcela, MD ; Han, Xia, MS ; Tiwari, Ranjan, MSc ; Salles, Gilles, MD ; Maziarz, Richard T, MD

Publisher:London: Elsevier Ltd

Journal title:The lancet oncology, 2021-10, Vol.22 (10), p.1403-1415

View online as a Library member

Search the collection

Export record to excel

Export this record

Export record to excel

Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study

Refine your search